Login| Sign Up| Help| Contact|

Patent Searching and Data


Document Type and Number:
Japanese Patent JPH07504900
Kind Code:
A
Abstract:
Viral infection is inhibited in mammals by administration of metabolically stable, non-toxic 2',5'-oligoadenylate (2-5A) derivatives that have a dual therapeutic effect. The compounds activate the intracellular latent 2-5A dependent endoribonuclease RNase L and also inhibit the action of viral DNA polymerases. Conjugates of the 2-5A derivatives for therapeutic delivery are also described.

More Like This:
WO/1999/008536ANTIVIRAL AGENT
JP2935518INDUSTRIAL APPLICABILITY The dermatological composition consisting of an extract of lamellar grass or at least one component of the extract, particularly an anti-allergic, anti-inflammatory, anti-aging composition, and a cosmetic or pharmaceutical composition. Hydrate lipid lamellar phase or liposome-based composition
Application Number:
JP51569893A
Publication Date:
June 01, 1995
Filing Date:
February 18, 1993
Export Citation:
Click for automatic bibliography generation   Help
International Classes:
A61K31/70; A61K31/7088; A61K31/74; C07H21/04; A61P31/12; C07H21/00; C07J43/00; C07J51/00; C08B37/00; (IPC1-7): C07H21/04; A61K31/70; C08B37/00



 
Previous Patent: JPH07504899

Next Patent: JPH07504901